J. W. Coons Advisors LLC Makes New Investment in The Clorox Company (NYSE:CLX)

J. W. Coons Advisors LLC purchased a new stake in shares of The Clorox Company (NYSE:CLXFree Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 1,500 shares of the company’s stock, valued at approximately $214,000.

Several other large investors have also made changes to their positions in CLX. Atria Wealth Solutions Inc. grew its position in Clorox by 13.7% in the third quarter. Atria Wealth Solutions Inc. now owns 22,077 shares of the company’s stock worth $2,893,000 after acquiring an additional 2,663 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Clorox by 0.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 663,638 shares of the company’s stock worth $86,963,000 after purchasing an additional 3,696 shares in the last quarter. Burney Co. increased its position in Clorox by 5.3% during the third quarter. Burney Co. now owns 4,848 shares of the company’s stock worth $635,000 after buying an additional 245 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its position in shares of Clorox by 8.4% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 8,707 shares of the company’s stock worth $1,141,000 after buying an additional 676 shares during the last quarter. Finally, Pathstone Family Office LLC lifted its position in shares of Clorox by 379.7% in the third quarter. Pathstone Family Office LLC now owns 9,144 shares of the company’s stock worth $1,198,000 after buying an additional 7,238 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX stock opened at $132.97 on Friday. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a market capitalization of $16.51 billion, a P/E ratio of 68.90, a P/E/G ratio of 2.04 and a beta of 0.39. The stock has a 50 day moving average of $139.82 and a two-hundred day moving average of $144.53. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same period last year, the business earned $1.51 earnings per share. As a group, equities analysts expect that The Clorox Company will post 5.83 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CLX. The Goldman Sachs Group began coverage on Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective on the stock. DA Davidson reissued a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. UBS Group reduced their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Citigroup lowered their target price on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Finally, Morgan Stanley reissued an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and an average target price of $146.43.

Read Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.